Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Embryonic Stem Cells00:58

Embryonic Stem Cells

33.5K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
33.5K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

6.1K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
6.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An integrated hydrogel-V3 interneuron therapy promotes functional repair of spinal cord injury via neural circuit reconstruction and microenvironment remodeling.

Bioactive materials·2026
Same author

Comparative effectiveness of different inhaler technique education modalities on clinical outcomes in patients with asthma and chronic obstructive pulmonary disease: a protocol for a systematic review and network meta-analysis of randomised controlled trials.

BMJ open·2026
Same author

Acetonitrile-driven interface force field reconstruction of HLB-SPME: insight into the pesticide adsorption mechanism based on energy lattice point models.

Analytical methods : advancing methods and applications·2026
Same author

A systematic review on mindfulness-based immersive interventions in depressive disorders.

Npj mental health research·2026
Same author

Primary cutaneous epithelioid hemangioendothelioma of the temporal region: a case report.

The Pan African medical journal·2026
Same author

Innovative 3D structured light technology for robotic-assisted surgery in selected spontaneous medium-volume basal ganglia hematomas: enhancing precision, surgical nuance, and clinical outcomes.

BMC surgery·2026

Related Experiment Video

Updated: Apr 13, 2026

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
08:52

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Published on: June 13, 2018

9.4K

Developing osteoblasts as an endpoint for the mouse embryonic stem cell test.

Xinrong Chen1, Deborah K Hansen1, Gwenn Merry1

  • 1Division of Systems Biology, National Center for Toxicological Research, Food and Drug Administration.

Reproductive Toxicology (Elmsford, N.Y.)
|May 2, 2015
PubMed
Summary

Adding osteoblast differentiation to the mouse Embryonic Stem cell Test (EST) can enhance its predictive value for embryotoxicity. This in vitro assay shows comparable results to the cardiomyocyte endpoint, offering confirmatory data for chemical safety assessments.

Keywords:
Alternative modelCardiomyocyteEmbryonic stem cell testEmbryotoxicityIn vitroOsteoblast

More Related Videos

Author Spotlight: Advancing Treatment Approaches with Adipose-Derived Stem Cells
04:53

Author Spotlight: Advancing Treatment Approaches with Adipose-Derived Stem Cells

Published on: January 12, 2024

1.8K
Differentiation of Embryonic Stem Cells into Oligodendrocyte Precursors
08:11

Differentiation of Embryonic Stem Cells into Oligodendrocyte Precursors

Published on: May 19, 2010

15.9K

Related Experiment Videos

Last Updated: Apr 13, 2026

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
08:52

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Published on: June 13, 2018

9.4K
Author Spotlight: Advancing Treatment Approaches with Adipose-Derived Stem Cells
04:53

Author Spotlight: Advancing Treatment Approaches with Adipose-Derived Stem Cells

Published on: January 12, 2024

1.8K
Differentiation of Embryonic Stem Cells into Oligodendrocyte Precursors
08:11

Differentiation of Embryonic Stem Cells into Oligodendrocyte Precursors

Published on: May 19, 2010

15.9K

Area of Science:

  • Toxicology
  • Developmental Biology
  • Stem Cell Research

Background:

  • The mouse Embryonic Stem cell Test (EST) is a valuable in vitro assay for predicting embryotoxicity.
  • Current EST models primarily use cardiomyocyte differentiation, but incorporating additional endpoints may improve predictive accuracy.

Purpose of the Study:

  • To investigate the utility of osteoblast differentiation as an additional endpoint in the mouse Embryonic Stem cell Test (EST).
  • To assess whether adding an osteoblast differentiation endpoint improves the predictive value for embryotoxicity detection.

Main Methods:

  • A 14-day direct plating method using D3 mouse embryonic stem cells (mESCs) was employed.
  • Twelve compounds, including eight from the EST validation study and four known skeletal defect-inducing agents, were tested.
  • Variables such as culture conditions and initial cell number were optimized.

Main Results:

  • Osteoblast differentiation demonstrated comparable chemical classification to the established cardiomyocyte differentiation endpoint.
  • The study successfully developed a prediction model for osteoblast differentiation within the EST framework.
  • Results suggest osteoblast differentiation can provide confirmatory evidence for embryotoxicity prediction.

Conclusions:

  • Osteoblast differentiation serves as a viable and potentially confirmatory endpoint for the mouse Embryonic Stem cell Test (EST).
  • Integrating osteoblast differentiation may enhance the overall reliability and predictive power of in vitro embryotoxicity assays.
  • This approach contributes to improved chemical safety assessments and the understanding of developmental toxicity mechanisms.